Movement disorders of autoimmune origin

Movement Disorders in Neurologic and Systemic Disease

Volumn , Issue , 2012, Pages 52-72

  Baizabal Carvallo, José Fidel ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928086847     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139175845.006     Document Type: Chapter

References (111)

1. Abele, M., Bürk, K., Schöls, L., Schwartz, S., Besenthal, I., Dichgans, J., et al. (2002). “The aetiology of sporadic adult-onset ataxia,” Brain 125: 961–8.
2. Abou-Zeid, E., Boursoulian, L. J., Metzer, W. S., and Gundogdu, B. (2012). “Morvan syndrome: a case report and review of the literature,” J. Clin. Neuromuscul. Dis. 13: 214–27.
3. Akman-Demir, G., Serdaroglu, P., and Tasci, B. (1999). “Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group,” Brain 122: 2171–82.
4. Alberca, R. A., Romero, M., and Chaparro, J. (1982). “Jerking stiff-man syndrome,” J. Neurol. Neurosurg. Psychiatry 45: 1159–60.
5. Al Jishi, F., Al Kawi, M. Z., El Ramahi, K., and Omer, S. (1995). “Hemichorea in systemic lupus erythematosus: significance of MRI findings,” Lupus 4: 321–3.
6. Ali, F., Rowley, M., Jayakrishnan, B., Teuber, S., Gershwin, M. E., and Mackay, I. R. (2011). “Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies,” J. Autoimmun. 37: 79–87.
7. Alonso-Navarro, H., Arroyo, M., Parra, A., and Jiménez-Jiménez, F. J. (2009). “Paroxysmal dystonia associated to primary Sjögren’s syndrome,” Mov. Disord. 24: 788–90.
8. Appenzeller, S., Cendes, F., and Costallat, L. T. (2008). “Cerebellar ataxia in systemic lupus erythematosus,” Lupus 17: 1122–6.
9. Asherson, R. A., Derksen, R. H., Harris, E. N., Bouma, B. N., Gharavi, A. E., Kater, L., and Hughes, G. R. (1987). “Chorea in systemic lupus erythematosus and ‘lupus-like’ disease: association with antiphospholipid antibodies,” Semin. Arthritis Rheum. 16: 253–9.
10. Baizabal-Carvallo, J. F., Alonso-Juarez, M., and Koslowski, M. (2011). “Chorea in systemic lupus erythematosus,” J. Clin. Rheumatol. 17: 69–72.
11. Baizabal-Carvallo, J. F. and Jankovic, J. (2012). “Movement disorders in autoimmune diseases,” Mov. Disord. 27: 935–46.
12. Benamour, S., Naji, T., Alaoui, F. Z., El-Kabli, H., and El-Aidouni, S. (2006). “Neurological involvement in Behçet’s disease 154 cases from a cohort of 925 patients and review of the literature,” Rev. Neurol. (Paris) 162: 1084–90.
13. Bertsias, G. K., Ioannidis, J. P., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., et al. (2010). “EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs,” Ann. Rheum. Dis. 69: 2074–82.
14. Bhatia, K. P., Brown, P., Gregory, R., Lennox, G. G., Manji, H., Thompson, P. D., et al. (1995). “Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum,” Brain 118: 1087–93.
15. Blank, M., Krause, I., Magrini, L., Spina, G., Kalil, J., Jacobsen, S., et al. (2006). “Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome,” Rheumatology (Oxford) 45: 833–41.
16. Blum, P. and Jankovic, J. (1991). “Stiff-person syndrome: An autoimmune disease,” Mov. Disord. 6: 12–20.
17. Bogdanova, D., Milanov, I., and Georgiev, D. (1998). “Parkinsonian syndrome as a neurological manifestation of Behçet’s disease,” Can. J. Neurol. Sci. 25: 82–5.
18. Boscolo, S., Sarich, A., Lorenzon, A., Passoni, M., Rui, V., Stebel, M., et al. (2007). “Gluten ataxia: passive transfer in a mouse model,” Ann. N. Y. Acad. Sci. 1107: 319–28.
19. Brain, L., Jellinek, E. H., and Ball, K. (1966). “Hashimoto’s disease and encephalopathy,” Lancet Neurol. 2: 512–14.
20. Bürk, K., Bösch, S., Müller, C. A., Melms, A., Zühlke, C., Stern, M., et al. (2001a). “Sporadic cerebellar ataxia associated with gluten sensitivity,” Brain 124: 1013–19.
21. Bürk, K., Melms, A., Schulz, J. B., and Dichgans, J. (2001b). “Effectiveness of intravenous immunoglobulin therapy in cerebellar ataxia associated with gluten sensitivity,” Ann. Neurol. 50: 827–8.
22. Cairo, H., Bode, H., Debatin, K. M., Opladen, T., and Schwarz, K. (2009). “Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment,” Neurology 73: 2127–9.
23. Campbell, A. M. and Garland, H. (1956). “Subacute myoclonic spinal neuronitis,” J. Neurol. Neurosurg. Psychiatry 19: 268–74.
24. Castillo, P., Woodruff, B., Caselli, R., Vernino, S., Lucchinetti, C., Swanson, J., et al. (2006). “Steroid-responsive encephalopathy associated with autoimmune thyroiditis,” Arch. Neurol. 63: 197–202.
25. Cervera, R., Asherson, R. A., Font, J., Tikly, M., Pallares, L., Chamorro, A., et al. (1997). “Chorea in the antiphospholipid syndrome: clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature,” Medicine (Baltimore) 76: 203–12.
26. Dalakas, M. C. (2011). “Stiff person syndrome: advances in pathogenesis and therapeutic interventions,” Curr. Treat. Options Neurol. 11: 102–10.
27. Dalakas, M. C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., and McElroy, B. (2001). “High-dose intravenous immune globulin for stiff-person syndrome,” N. Engl. J. Med. 345: 1870–6.
28. Dale, R. C., Yin, K., Ding, A., Merheb, V., Varadkhar, S., McKay, D., et al. (2011). “Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies,” Dev. Med. Child Neurol. 53: 522–8.
29. Delalande, S., de Seze, J., Fauchais, A. L. (2004). “Neurologic manifestations in primary Sjögren’s syndrome: a study of 82 patients,” Medicine (Baltimore) 83: 280–91.
30. Dinkel, K., Meinck, H. M., Jury, K. M., Karges, W., and Richter, W. (1998). “Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome,” Ann. Neurol. 44: 194–201.
31. Duddy, M. E. and Baker, M. R. (2009). “Stiff person syndrome,” Front Neurol. Neurosci. 29: 147–65.
32. Economides, J. R. and Horton, J. C. (2005). “Eye movement abnormalities in stiff person syndrome,” Neurology 65: 1462–4.
33. Fekete, R. and Jankovic, J. (2012). “Childhood stiff-person syndrome improved with rituximab,” Case Rep. Neurol. 4: 92–6.
34. Ferracci, F., Bertiato, G., and Moretto, G. (2004). “Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations,” J. Neurol. Sci. 217: 165–8.
35. Ferracci, F. and Carnevale, A. (2006). “The neurological disorder associated with thyroid autoimmunity,” J. Neurol. 253: 975–84.
36. Floeter, M. K., Valls-Sole, J., Toro, C., Jacobowitz, D., and Hallet, M. (1998). “Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome,” Neurology 51: 85–93.
37. Forchetti, C. M., Katsamakis, G., and Garron, D. C. (1997). “Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism,” Neurology 49: 623–6.
38. Freeman, H. J. (2008). “Neurological disorders in adult celiac disease,” Can. J. Gastroenterol. 22: 909–11.
39. Fujii, A., Yoneda, M., Ito, T., Yamamura, O., Satomi, S., Higa, H., et al. (2005). “Autoantibodies against the amino terminal of α-enolase are a useful diagnostic marker of Hashimoto’s encephalopathy,” J. Neuroimmunol. 162: 130–6.
40. Furie, R., Ishikawa, T., Dhawan, V., and Eidelberg, D. (1994). “Alternating hemichorea in primary antiphospholipid syndrome: evidence for contralateral striatal hypermetabolism,” Neurology 44: 2197–9.
41. Galanaud, D., Dormont, D., Marsault, C., Wechsler, B., and Piette, J. C. (2000). “Brain MRI in patients with past lupus-associated chorea,” Stroke 31: 3079–83.
42. Garcia-Cazorla, A., Quadros, E. V., Nascimento, A., Garcia-Silva, M. T., Briones, P., Montoya, J., et al. (2008). “Mitochondrial diseases associated with cerebral folate deficiency,” Neurology 70: 1360–2.
43. Garcia-Moreno, J. M. and Chacon, J. (2002). “Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature,” Mov. Disord. 17: 1329–35.
44. Geis, C., Weishaupt, A., Grünewald, B., Wultsch, T., Reif, A., Gerlach, M., et al. (2011). “Human stiff-person syndrome IgG induces anxious behavior in rats,” PLoS One 6: e16775.
45. Goëb, V., Dubreuil, F., Cabre, P., Jean Baptiste, G., and Arfi, S. (2004). “Lupus revealing itself after a stiff-person syndrome,” Lupus 13: 215.
46. Gonzalez Aleman, G., Florenzano, N., Padilla, E., Bourdieu, M., Guerrero, G., Calvó, M., et al. (2006). “A 37-year-old woman with celiac disease, recurrent psychosis, and parkinsonism,” Mov. Disord. 21: 729–31.
47. Hadjivassiliou, M., Davies-Jones, G. A. B., Sanders, D. S., and Grünewald, R. A. G. (2003a). “Dietary treatment of gluten ataxia,” J. Neurol. Neurosurg. Psychiatry 74: 1221–4.
48. Hadjivassiliou, M., Grünewald, R. A., Chattopadhyay, A. K., Davies-Jones, G. A., Gibson, A., Jarratt, J. A., et al. (1998). “Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia,” Lancet Neurol. 352: 1582–5.
49. Hadjivassiliou, M., Grünewald, R., Sharrack, B., Sanders, D., Lobo, A., Williamson, C., et al. (2003b). “Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics,” Brain 126: 685–91.
50. Hadjivassiliou, M., Mäki, M., Sanders, D. S., Williamson, C. A., Grünewald, R. A., Woodroofe, N. M., et al. (2006). “Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia,” Neurology 66: 373–7.
51. Hadjivassiliou, M., Sanders, D. S., Woodoofe, N., Boscolo, S., and Aeschlimann, D. (2010). “Gluten sensitivity: from gut to brain,” Lancet Neurol. 9: 318–30.
52. Hall, D. A., Parsons, J., and Benke, T. (2007). “Paroxysmal nonkinesigenic dystonia and celiac disease,” Mov. Disord. 22: 708–10.
53. Hassin-Baer, S., Levy, Y., Langevitz, P., Nakar, S., and Ehrenfeld, M. (2007). “Anti-beta2-glycoprotein I in Sjögren’s syndrome is associated with parkinsonism,” Clin. Rheumatol. 26: 743–7.
54. Hyland, K., Shoffner, J., and Heales, S. J. (2010). “Cerebral folate deficiency,” J. Inherit. Metab. Dis. 33: 563–70.
55. Ihara, M., Makino, F., Sawada, H., Mezaki, T., Mizutani, K., Nakase, H., et al. (2006). “Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia,” Intern. Med. 45: 135–40.
56. Irani, S. R., Pettingill, P., Kleopa, K. A., Schiza, N., Waters, P., Mazia, C., et al. (2012). “Morvan syndrome: clinical and serological observations in 29 cases,” Ann. Neurol. 72: 241–55.
57. Jankovic, J. (2009). “Treatment of hyperkinetic movement disorders,” Lancet Neurol. 8: 844–56.
58. Jankovic, J. and Patten, B. M. (1987). “Blepharospasm and autoimmune diseases,” Mov. Disord. 2: 159–63.
59. Joseph, F. G., Lammie, G. A., and Scolding, N. J. (2007). “CNS lupus: a study of 41 patients,” Neurology 14(69): 644–54.
60. Joseph, F. G. and Scolding, N. J. (2007). “Neuro-Behçet’s disease in Caucasians: a study of 22 patients,” Eur. J. Neurol. 14: 174–80.
61. Khamashta, M. A., Gil, A., Anciones, B., Lavilla, P., Valencia, M. E., Pintado, V., et al. (1988). “Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies,” Ann. Rheum. Dis. 47: 681–3.
62. Khubchandani, R. P., Viswanathan, V., and Desai, J. (2007). “Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE,” Lupus 16: 572–5.
63. Klaas, J. P., Ahlskog, J. E., Pittock, S. J., Matsumoto, J. Y., Aksamit, A. J., Bartleson, J. D., et al. (2012). “Adult-onset opsoclonus-myoclonus syndrome,” Arch. Neurol. 17: 1–10.
64. Koerner, C., Wieland, B., Richter, W., and Meinck, H. M. (2004). “Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-GAD autoimmunity,” Neurology 62: 1357–62.
65. Kok, J., Bosseray, A., Brion, J. P., Micoud, M., and Besson, G. (1993). “Chorea in a child with Churg-Strauss syndrome,” Stroke 24: 1263–4.
66. Krakauer, M. and Law, I. (2009). “FDG PET brain imaging in neuropsychiatric systemic lupus erythematosis with choreic symptoms,” Clin. Nucl. Med. 34: 122–3.
67. Kunas, R. C., McRae, A., Kesselring, J., and Villiger, P.M. (1995). “Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson’s disease,” J. Allergy Clin. Immunol. 96: 688–90.
68. Kurian, M., Lalive, P. H., Dalmau, J. O., and Horvath, J. (2010). “Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis,” Arch. Neurol. 67: 118–21.
69. Kuriwaka, R., Kunishige, M., Nakahira, H., Inoue, H., Higashi, T., Tokumoto, Y., et al. (2004). “Neuro-Behçet’s disease with chorea after remission of intestinal Behçet’s disease,” Clin. Rheumatol. 23: 364–7.
70. Lazurova, I., Macejova, Z., Benhatchi, K., Oetterova, M., Antolova, E., Asherson, R. A., et al. (2007). “Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea,” Clin. Rheumatol. 26: 2145–7.
71. Lee, P. H., Joo, U. S., Bang, O. Y., Seo, C. H. (2004). “Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism,” Neurology 63: 395–6.
72. Levy, L. M., Levy-Reis, I., Fujii, M., and Dalakas, M. C. (2005). “Brain gamma-aminobutyric acid changes in stiff-person syndrome,” Arch. Neurol. 62: 970–4.
73. Liu, B. and Dluzen, D. E. (2007). “Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson’s disease,” Clin. Exp. Pharmacol. Physiol. 34: 555–65.
74. Lohmann, T., Hawa, M., Leslie, R. D., Lane, R., Picard, J., and Londei, M. (2000). “Immune reactivity to glutamic acid decarboxylase 65 in stiff-man syndrome and type 1 diabetes mellitus,” Lancet Neurol. 356: 31–5.
75. Mahad, D., Oates, K., Williams, C., Grunewald, R. A., Howell, S. J. L., Woodroofe, M. N., et al. (2002). “Gluten ataxia is immune mediated,” J. Neurol. Neurosurg. Psychiatry 72: 140.
76. Martino, D., Chew, N. K., Mir, P., Edwards, M. J., Quinn, N. P., and Bhatia, K. P. (2006). “Atypical movement disorders in antiphospholipid syndrome,” Mov. Disord. 21: 944–9.
77. Mas, N., Saiz, A., Leite, M. I., Waters, P., Baron, M., Castano, D., et al. (2011). “Antiglycine-receptor encephalomyelitis with rigidity,” J. Neurol. Neurosurg. Psychiatry 82: 1399–401.
78. Mayo, J., Arias, M., Leno, C., and Berciano, J. (1986). “Vascular parkinsonism and periarteritis nodosa,” Neurology 36: 874–5.
79. McKeon, A., Robinson, M. T., McEvoy, K. M., Matsumoto, J. Y., Lennon, V. A., Ahlskog, J. E., et al. (2012). “Stiff-man syndrome and variants: clinical course, treatments, and outcomes,” Arch. Neurol. 69: 230–8.
80. Meinck, H. M., Tronnier, V., Rieke, K., Wirtz, C. R., Flügel, D., and Schwab, S. (1994). “Intrathecal baclofen treatment for stiff-man syndrome: pump failure may be fatal,” Neurology 44: 2209–10.
81. Min, J. H. and Youn, Y. C. (2009). “Bilateral basal ganglia lesions of primary Sjögren’s syndrome presenting with generalized chorea,” Parkinsonism Relat. Disord. 15: 398–9.
82. Mocellin, R., Walterfang, M., and Velakoulis, D. (2007). “Hashimoto’s encephalopathy: epidemiology, pathogenesis and management,” CNS Drugs 21: 799–811.
83. Moersch, F. P. and Woltman, H. W. (1956). “Progressive fluctuating muscular rigidity and spasm (’stiff-man’ syndrome); report of a case and some observations in 13 other cases,” Proc. Staff Meet Mayo Clin. 31: 421–7.
84. Moretti, P., Sahoo, T., Hyland, K., Bottiglieri, T., Peters, S., del Gaudio, D., et al. (2005). “Cerebral folate deficiency with developmental delay, autism, and response to folinic acid,” Neurology 64: 1088–90.
85. Munhoz, R. P., Fameli, H., and Teive, H. A. G. (2010). “Stiff person syndrome as the initial manifestation of systemic lupus erythematosus,” Mov. Disord. 25: 516–17.
86. Murinson, B. B. and Murinson, J. B. (2008). “Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease,” Neurology 71: 1955–8.
87. Ormazabal, A., Artuch, R., Vilaseca, M. A., Aracil, A., and Pineda, M. (2005). “Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid,” Neuropediatrics 36: 380–5.
88. Orzechowski, N. M., Wolanskyj, A. P., Ahlskog, J. E., Kumar, N., and Moder, K. G. (2008). “Antiphospholipid antibody-associated chorea,” J. Rheumatol. 35: 2165–70.
89. Pellecchia, M. T., Ambrosio, G., Salvatore, E., Vitale, C., De Michele, G., and Barone, P. (2002). “Possible gluten sensitivity in multiple system atrophy,” Neurology 59: 1114–15.
90. Perani, D., Garibotto, V., Moresco, R. M., Ortelli, P., Corbo, M., Fazio, F., et al. (2007). “PET evidence of central GABAergic changes in stiff-person syndrome,” Mov. Disord. 22: 1030–3.
91. Pereira, A. C., Edwards, M. J., Buttery, P. C., Hawkes, C. H., Quinn, N. P., Giovannoni, G., et al. (2004). “Choreic syndrome and coeliac disease: a hitherto unrecognized association,” Mov. Disord. 19: 478–82.
92. Piccolo, I., Defanti, C. A., Soliveri, P., Volontè, M. A., Cislaghi, G., and Girotti, F. (2003). “Cause and course in a series of patients with sporadic chorea,” J. Neurol. 250: 429–35.
93. Pozo-Rosich, P., Villoslada, P., Canton, A., Simo, R., Rovira, A., and Montalban Xavier, I. (2002). “Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease,” J. Neurol. 249: 1063–5.
94. Raju, R., Rakocevic, G., Chen, Z., Hoehn, G., Semino-Mora, C., Shi, W., et al. (2006). “Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome,” Brain 129: 3270–6.
95. Ramaekers, V. T., Rothenberg, S. P., Sequeira, J. M., Opladen, T., Blau, N., Quadros, E. V., et al. (2005). “Autoantibodies to folate receptors in the cerebral folate deficiency syndrome,” N. Engl. J. Med. 352: 1985–91.
96. Ramaekers, V. T., Sequeira, J. M., Blau, N., and Quadros, E. V. (2008). “A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome,” Dev. Med. Child Neurol. 50: 346–52.
97. Reiner, P., Galanaud, D., Leroux, G., Vidailhet, M., Haroche, J., and Huong, D. L. (2011). “Long-term outcome of 32 patients with chorea and systemic lupus erythematosus and antiphospholipid syndrome,” Mov. Disord. 26: 2422–47.
98. Revilla, F. J., Racette, B. A., and Perlmutter, J. S. (2000). “Chorea and jaw-opening dystonia as a manifestation of Neuro-Behçet’s syndrome,” Mov. Disord. 15: 741–4.
99. Ruiz-Irastorza, G., Crowther, M., Branch, W., and Khamashta, M. A. (2010). “Antiphospholipid syndrome,” Lancet Neurol. 376: 1498–509.
100. Santambrogio, L., Bellomo, G., Mercuri, M., Alagia, G., and Ciuffetti, G. (1990). “Temporal arteritis presenting as an extrapyramidal disorder,” Acta Neurol. Scand. 81: 361–2.
101. Serdaroglu, P. (1998). “Behçet’s disease and the nervous system,” J. Neurol. 245: 197–205.
102. Singer, H. S., Krumholz, A., Giuliano, J., and Kiessling, L. S. (1997). “Antiphospholipid antibodies: An epiphenomenon in Tourette syndrome,” Mov. Disord. 12:738–42.
103. Solimena, M., Folli, F., Denis-Donini, S., Comi, G. C., Pozza, G., De Camilli, P., et al. (1988). “Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus,” N. Engl. J. Med. 318: 1012–20.
104. Tan, E. K., Chan, T. T., and Auchus, A. P. (2001). “Reversible parkinsonism in systemic lupus erythematosus,” J. Neurol. Sci. 193: 53–7.
105. Tsokos, G.C. (2011). “Systemic lupus erythematosus,” N. Engl. J. Med. 365:2110–21.
106. van den Berg, J. S., Horstink, M. W., van den Hoogen, F. H., and Oyen, W. J. (1999). “Dystonia; a central nervous system presentation of Sjögren’s syndrome,” Mov. Disord. 14: 374–5.
107. Walker, R. H., Spiera, H., Brin, M. F., and Olanow, C. W. (1999). “Parkinsonism associated with Sjögren’s syndrome: three cases and a review of the literature,” Mov. Disord. 14: 262–8.
108. Whiterick, J., Highley, J. R., and Hadjivassiliou, M. (2011). “Pathological findings in a case of stiff person syndrome with anti-GAD antibodies,” Mov. Disord. 26: 2138–9.
109. Wilkinson, I. D., Hadjivassiliou, M., Dickson, J. M., Wallis, L., Grünewald, R. A., Coley, S. C., et al. (2005). “Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia,” J. Neurol. Neurosurg. Psychiatry 76: 1011–13.
110. Yoneda, M., Fujii, A., Ito, A., Yokoyama, H., Nakagawa, H., and Kuriyama, M. (2007). “High-prevalence of serum autoantibodies against the amino-terminal of α-enolase in Hashimoto’s encephalopathy,” J. Neuroimmunol. 185: 195–200.
111. Zelnik, N., Pacht, A., Obeid, R., and Lerner, A. (2004). “Range of neurologic disorders in patients with celiac disease,” Pediatrics 113: 1672–6.